XTRA LIGHTENING COCKTAIL

5 vials of 5 ml

Clarifying anti-spot with peptides

XTRA Lightening acts by reducing melanin synthesis, age spots, and freckles.

XTRA Lightening provides a clarifying, brightening, homogenizing, and depigmenting effect on the skin, restoring its vitality, radiance, and transparency.

Use of XTRA Lightening:

• 8 to 12 mesotherapy sessions, one week apart

Arbutin: effectively inhibits tyrosinase activity and, consequently, melanin production. Due to structural similarities with tyrosinase substrates, arbutin acts via a competitive binding mechanism in the enzyme's active sites.

Furthermore, arbutin has the ability to inhibit DHICA polymerase (5,6-dihydroxy-indole-2-carboxylic acid) produced from tyrosine oxidation.

Glycyrrhiza uralensis (licorice) root extract: inhibition of the tyrosinase enzyme, and a slight action reducing melanin precursors and color.

Licorice extract also has anti-inflammatory properties by inhibiting superoxide anion synthesis and cyclooxygenase activity.

Anti-aging effect by effectively absorbing UVA and B rays. Anti-radical.

3-O-ethyl Ascorbic Acid: The depigmenting activity of ascorbic acid is due to both its tyrosinase inhibitory action and its ability to reduce dopaquinone to DOPA, which can also prevent melanin formation.

Cromabright™: inhibits tyrosinase activity. Significant depigmenting effect in melanocytes. It produces a powerful skin whitening effect in vivo. Photoprotective effect on cell cultures of human epidermal keratinocytes, acting as a preventive measure against skin damage induced by ultraviolet radiation.

Pentapeptide-13: Provides clarifying, skin tone homogenizing properties.

Decapeptide-15 Antioxidant: Clarifies and whitens skin.

Prevents photoaging. Inhibits melanin synthesis by a mechanism of tyrosinase expression inhibition.

Oligopeptide-50: Inhibits melanin synthesis by inhibiting tyrosinase. Changes the morphology of melanocytes. Induces the reduction of melanin synthesis and melanosome formation in melanocytes. Inhibits the expression of the melanogenesis marker.

Oligopeptide-34: inhibits melanin synthesis. Reduces tyrosinase activity. It produces a decrease in melanosome formation in treated melanocytes.

Oligopeptide-51 inhibits the expression of the melanogenesis marker. It inhibits melanin synthesis. Induces morphological changes in melanocytes.

Glutathione: Glutathione has a reducing SH group.

This functional group can form a complex with copper and by reducing dopaquinone. Glutathione induces the formation of pheomelanin from dopaquinone.